phrykt

Pharvaris N.V. (PHVS): who owns it and who trades it

As of Nov 16, 2026, PHVS insiders reported 65 open-market sales worth $32.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Johannes Gerardus Christiaan Petrus Schikan (Director), with $9.7M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Pharvaris

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PHVS

125 funds and institutions reported PHVS shares worth $2.3B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is FMR LLC (Fidelity) with 10.1%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

FMR LLC (Fidelity)10.1%
General Atlantic, L.P.10.0%
Foresite Capital Management IV, LLC7.3%
VenBio Partners LLC7.1%
Viking Global Investors LP5.6%
EQT Fund Management S.a r.l.5.3%
Deerfield Management Company, L.P.5.2%
Bain Capital Life Sciences Investors, LLC4.1%
Wellington Management Group LLP3.7%
Polar Capital Holdings Plc3.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
FMR LLC (Fidelity)6.57M10.07%$227M+4%
General Atlantic, L.P.6.55M10.05%$227M-18%
Foresite Capital Management IV, LLC4.78M7.33%$165MNo change
VenBio Partners LLC4.64M7.12%$161M+0%
Viking Global Investors LP3.65M5.60%$126MNo change
EQT Fund Management S.a r.l.3.42M5.25%$118MNo change
Deerfield Management Company, L.P.3.38M5.18%$117M+8%
Bain Capital Life Sciences Investors, LLC2.68M4.10%$92.5MNo change
Wellington Management Group LLP2.39M3.67%$82.7M+13%
Polar Capital Holdings Plc2.33M3.57%$80.4M+198%
Point72 Asset Management, L.P.1.64M2.52%$56.8M+63%
Commodore Capital LP1.43M2.19%$49.3M-26%
Novo Holdings A/s1.40M2.15%$48.4M-20%
Saturn V Capital Management LP1.31M2.02%$45.4M+9%
TCG Crossover Management, LLC1.01M1.55%$34.9M–
Sofinnova Investments, Inc.881,2991.35%$30.5M+8%
California State Teachers Retirement System799,4901.23%$23.1M+3210%
5AM Venture Management, LLC797,6001.22%$27.6MNo change
Seven Fleet Capital Management LP774,5011.19%$26.8M+348%
BlackRock, Inc.771,4541.18%$26.7M+2%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PHVS insiders reported $0 of open-market purchases and $32.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$32.5M
65 trades, 11 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Sep 23, 2026
Filed Sep 25, 2026

Purchases and sales by month

$20.3M$20.3MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Sep 23, 2026Viviane MongesDirectorSale11,969$33.05$396KForm 4
Sep 22, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale800$36.19$29KForm 4
Sep 21, 2026David W. NassifCFOSale6,000$36.47$219KForm 4
Sep 17, 2026Peng LuPresidentSale100,000$35.00$3.5MForm 4
Sep 17, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale200,000$35.00$7MForm 4
Sep 17, 2026Elisabeth BjorkDirectorSale52,500$37.89$2MForm 4
Sep 17, 2026Robert GlassmanDirectorSale14,493$38.56$559KForm 4
Sep 17, 2026Anne LesageChief Early DevelopmentSale20,000$38.27$765KForm 4
Sep 15, 2026Stefan Andreas AbeleChief Technical Ops OffiSale1,400$39.24$54.9KForm 4
Sep 15, 2026Stefan Andreas AbeleChief Technical Ops OffiSale45,000$38.14$1.7MForm 4
Sep 15, 2026Robert GlassmanDirectorSale8,667$38.27$332KForm 4
Sep 15, 2026Wim SouverijnsChief Commercial OfficerSale6,090$38.99$237KForm 4
Sep 14, 2026Wim SouverijnsChief Commercial OfficerSale20,000$39.31$786KForm 4
Sep 14, 2026Berndt ModigCEOSale2,291$39.40$90.3KForm 4
Sep 11, 2026Peng LuPresidentSale15,000$40.13$602KForm 4
Sep 10, 2026Anne LesageChief Early DevelopmentSale30,000$38.30$1.1MForm 4
Sep 9, 2026Robert GlassmanDirectorSale8,000$37.55$300KForm 4
Sep 8, 2026Peng LuPresidentSale15,000$40.68$610KForm 4
Aug 14, 2026Berndt ModigCEOSale2,292$34.77$79.7KForm 4
Jul 13, 2026Berndt ModigCEOSale2,292$34.97$80.2KForm 4
Jun 30, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale30,712$35.49$1.1MForm 4
Jun 30, 2026Anne LesageChief Early DevelopmentSale27,872$35.48$989KForm 4
Jun 30, 2026Anne LesageChief Early DevelopmentSale30,703$35.49$1.1MForm 4
Jun 29, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale6,888$35.05$241KForm 4
Jun 29, 2026Anne LesageChief Early DevelopmentSale2,300$35.12$80.8KForm 4
Jun 29, 2026Anne LesageChief Early DevelopmentSale8,300$35.05$291KForm 4
Jun 29, 2026Anne LesageChief Early DevelopmentSale6,997$35.05$245KForm 4
Jun 29, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale2,400$35.10$84.2KForm 4
Jun 26, 2026Peng LuChief Medical OfficerSale14,700$34.00$500KForm 4
Jun 25, 2026Anne LesageChief Early DevelopmentSale2,300$35.12$80.8KForm 4
Jun 25, 2026Peng LuChief Medical OfficerSale3,400$35.09$119KForm 4
Jun 25, 2026Peng LuChief Medical OfficerSale11,600$34.45$400KForm 4
Jun 18, 2026Peng LuChief Medical OfficerSale300$34.00$10.2KForm 4
Jun 15, 2026Berndt ModigCEOSale100$31.46$3.1KForm 4
Jun 15, 2026Berndt ModigCEOSale2,191$31.05$68KForm 4
Jun 4, 2026Anna NijdamPrincipal Accounting OffSale2,670$30.87$82.4KForm 4
May 22, 2026Anna NijdamPrincipal Accounting OffSale5,501$30.74$169KForm 4
May 21, 2026Viviane MongesDirectorSale9,667$30.29$293KForm 4
May 21, 2026Anna NijdamPrincipal Accounting OffSale1,829$30.60$56KForm 4
May 21, 2026David W. NassifCFOSale10,000$30.31$303KForm 4
May 20, 2026Elisabeth BjorkDirectorSale10,000$29.32$293KForm 4
May 18, 2026Berndt ModigCEOSale2,292$29.22$67KForm 4
May 15, 2026Robert GlassmanDirectorSale5,333$29.83$159KForm 4
May 15, 2026Robert GlassmanDirectorSale4,667$29.82$139KForm 4
May 15, 2026Stefan Andreas AbeleChief Technical Ops OffiSale8,748$29.82$261KForm 4
May 15, 2026Wim SouverijnsChief Commercial OfficerSale10,000$29.92$299KForm 4
May 1, 2026Peng LuChief Medical OfficerSale14,023$30.16$423KForm 4
May 1, 2026Peng LuChief Medical OfficerSale143$31.00$4.4KForm 4
Apr 30, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale670$31.03$20.8KForm 4
Apr 30, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale28,400$30.30$861KForm 4
Apr 30, 2026Anne LesageChief Early DevelopmentSale19,200$30.26$581KForm 4
Apr 30, 2026Anne LesageChief Early DevelopmentSale18,000$30.26$545KForm 4
Apr 30, 2026Anne LesageChief Early DevelopmentSale3,700$30.26$112KForm 4
Apr 30, 2026Peng LuChief Medical OfficerSale15,000$30.24$454KForm 4
Apr 29, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale3,830$30.07$115KForm 4
Apr 29, 2026Anne LesageChief Early DevelopmentSale3,700$30.08$111KForm 4
Apr 29, 2026Anne LesageChief Early DevelopmentSale3,700$30.06$111KForm 4
Apr 29, 2026Peng LuChief Medical OfficerSale3,733$30.06$112KForm 4
Apr 23, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale100$30.03$3KForm 4
Apr 22, 2026Johannes Gerardus Christiaan Petrus SchikanDirectorSale7,000$30.05$210KForm 4
Apr 22, 2026Anne LesageChief Early DevelopmentSale500$30.00$15KForm 4
Apr 22, 2026Peng LuChief Medical OfficerSale7,001$30.05$210KForm 4
Apr 16, 2026Berndt ModigCEOSale2,292$28.60$65.6KForm 4
Apr 9, 2026Berndt ModigCEOSale23,133$27.74$642KForm 4
Apr 9, 2026Berndt ModigCEOSale200$28.42$5.7KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Johannes Gerardus Christiaan Petrus SchikanDirector–$9.7MSep 22, 2026
Peng LuChief Medical Officer–$6.9MSep 17, 2026
Anne LesageChief Early Development–$6.2MSep 17, 2026
Elisabeth BjorkDirector–$2.3MSep 17, 2026
Stefan Andreas AbeleChief Technical Ops Officer–$2MSep 15, 2026
Robert GlassmanDirector–$1.5MSep 17, 2026
Wim SouverijnsChief Commercial Officer–$1.3MSep 15, 2026
Berndt ModigChief Executive Officer, Director–$1.1MSep 14, 2026
Viviane MongesDirector–$688KSep 23, 2026
David W. NassifCFO / CLO–$522KSep 21, 2026
Anna NijdamPrincipal Accounting Officer–$307KJun 4, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PHVS short interest

2.54M PHVS shares are sold short. Over the last 12 reports the number of shares short went up 323%.

As of Oct 30, 2026, 2.54M PHVS shares were sold short, up 3.0% from the report before. At the average daily volume of 708,619 shares, buying them all back would take about 3.6 trading days (days to cover).

Shares short, % of all shares

1.74%May 15Jul 151.87%

Days to cover

3.6May 15Oct 304.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20262.54M–+3%708,6193.6
Oct 15, 20262.47M–+23%614,0334.0
Sep 30, 20262.01M–+13%707,9912.8
Sep 15, 20261.78M–-17%1.44M1.2
Aug 31, 20262.16M–+22%638,8103.4
Aug 14, 20261.78M–+49%638,2012.8
Jul 31, 20261.19M–+5%313,5503.8
Jul 15, 20261.14M1.74%+15%676,4621.7
Jun 30, 2026985,9731.51%-12%434,6942.3
Jun 15, 20261.12M1.72%+58%377,8623.0
May 29, 2026708,6301.09%+18%270,6172.6
May 15, 2026600,6450.92%-43%463,8991.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Famous investors that hold PHVS

5 of the 50 well-known investors we track reported holding PHVS in their latest 13F filing. The largest position is Andreas Halvorsen's, worth $93M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Andreas Halvorsen · Viking Global InvestorsQ3 20262.93M$93M0.3%-20%
Steve Cohen · Point72 Asset ManagementQ3 20262.90M$92M0.2%+77%
Ken Griffin · Citadel AdvisorsQ3 2026483,054$15.3M0.0%+100%
Israel Englander · Millennium ManagementQ3 2026309,160$9.8M0.0%-28%
Paul Tudor Jones · Tudor Investment CorpQ3 202613,523$429K0.0%+3%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named PHVS in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Wellington Management Group LLP13G9.5%
Nov 16, 2026Wellington Management Group LLP13G9.5%
Nov 16, 2026VIKING GLOBAL INVESTORS LP13G/A4.5%
Nov 16, 2026VIKING GLOBAL INVESTORS LP13G/A4.5%
Nov 13, 2026GENERAL ATLANTIC, L.P.13G/A0.6%
Nov 13, 2026GENERAL ATLANTIC, L.P.13G/A0.6%

Questions about Pharvaris N.V. (PHVS) stock

Who owns the most PHVS stock?

The largest reported owner of Pharvaris N.V. (PHVS) is FMR LLC (Fidelity), with 10.1% of the company. In total, 125 funds and institutions reported holding PHVS at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are PHVS insiders buying or selling?

In the last 12 months, PHVS insiders reported no open-market purchases and 65 sales worth $32.5M. The latest trade was on Sep 23, 2026. See every trade.

What is the short interest in PHVS?

As of Oct 30, 2026, 2.54M PHVS shares were sold short, up 3.0% from the report before. At the average daily volume of 708,619 shares, buying them all back would take about 3.6 trading days (days to cover). See the history.

Which famous investors hold PHVS?

5 of the 50 well-known investors we track reported PHVS in their latest 13F filing, including Andreas Halvorsen, Steve Cohen, Ken Griffin. The largest position is worth $93M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.